Health Advocacy, Inc.: How Pharmaceutical Funding Changed the Breast Cancer Movement
| Author | : | |
| Rating | : | 4.33 (923 Votes) |
| Asin | : | 077483384X |
| Format Type | : | paperback |
| Number of Pages | : | 288 Pages |
| Publish Date | : | 2017-10-25 |
| Language | : | English |
DESCRIPTION:
Sharon Batt is an independent scholar and adjunct professor in the Department of Bioethics at Dalhousie University.
Health activist, scholar, award-winning journalist, and cancer survivor Sharon Batt investigates the relationship between patient advocacy groups and the pharmaceutical industry, as well as the contentious role of pharma funding. A movement that once encouraged democratic participation in the development of health policy now eerily echoes the demands of the pharmaceutical industry.. This analysis of Canada's breast cancer movement from 1990 to 2010 argues that the resulting power imbalance undermined the groups' ability to put patients' i
The resulting power imbalance continues to challenge the groups’ ability to put patients’ interests ahead of those of the industry. dissects the alliances between the companies that sell pharmaceuticals and the individuals who use them, drawing links between neoliberalism and corporate financing and the ensuing threat to the public health care system. Batt’s revelations about the relationship between patient advocacy groups and the pharmaceutical industry are vital and disturbing. (Lisa Cumming Maisonneuve 2017-04-01)Today, most pati